Fingerprint
Dive into the research topics of 'MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab
Research output: Contribution to journal › Letter › peer-review
9
Scopus
citations